ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,359.10
-0.13%
Dow Jones
39,671.04
-0.51%
Gold vs US Dollar
2,355.66
-1.10%
Brent Oil
81.715
0.23%
Bitcoin
69,730.77
0.91%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. OSE Immunotherapeutics (OSE) Share Price

OSE OSE Immunotherapeutics

8.44
0.11 (1.32%)
Last Updated: 08:59:03
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 OSE Immunotherapeutics EU:OSE Euronext Ordinary Share FR0012127173 
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.11 1.32 8.44 8.41 8.44 8.44 8.16 8.28 71,278 07:59:03   
 Type  Size  Price  Time  Units 
  25 8.44 07:59:24 EUR
 
Recent News
DateTimeSource
HeadlineMore OSE News
22/05/202406:30GLOBEOSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseases
22/05/202406:30GLOBEOSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseases
22/05/202406:30GLOBEOSE Immunotherapeutics et Boehringer Ingelheim étendent leur collaboration pour développer des traitements first-in-class dans le cancer et dans les maladies cardiovasculaires, rénales et métaboliques
13/05/202417:00GLOBEInformations relatives au nombre total de droits de vote et d’actions composant le capital
02/05/202417:00GLOBEMise à disposition du Document d’Enregistrement Universel incluant le Rapport Financier 2023
16/04/202417:00GLOBEOSE Immunotherapeutics’ Global License to Develop a Novel Monoclonal Antibody for the Treatment of Chronic Inflammation Becomes Effective
16/04/202417:00GLOBEOSE Immunotherapeutics annonce l’entrée en vigueur de la licence mondiale pour développer un anticorps monoclonal innovant dans le traitement de l’inflammation chronique
Period
Draw mode
Data Downloads for OSE

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest OSE Immunotherapeutics Articles